| Pharmaceutical active ingredients: |
| GuaifenesinPhenylephrine Hydrochloride |
| Available forms, composition and doses of Duraphen II: |
| N / A |
| Duraphen II medical category: |
| Human:Expectorants |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01BA53 - Phenylephrine, combinationsR05CA03 - GuaifenesinR05CA10 - Expectorants, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| ProEthic Pharmaceuticals |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Solubeol | Guaifenesin; Phenoxyethanol | Piette International |
| Crantex | Guaifenesin; Phenylephrine Hydrochloride | Breckenridge Pharmaceutical |
| Deconsal II | Guaifenesin; Phenylephrine Hydrochloride | Cornerstone Therapeutics |
| Deconsal Sprinkle | Guaifenesin; Phenylephrine Hydrochloride | Adams Laboratories |
| DF Expectorant NP | Guaifenesin; Phenylephrine Hydrochloride | Merck |
| Duratuss | Guaifenesin; Phenylephrine Hydrochloride | Victory Pharmaceuticals |
| Duratuss GP | Guaifenesin; Phenylephrine Hydrochloride | Victory Pharmaceuticals |
| Endal | Guaifenesin; Phenylephrine Hydrochloride | PediaMed Pharmaceuticals |
| Entex | Guaifenesin; Phenylephrine Hydrochloride | Andrx Pharmaceuticals; Purdue Pharma |
| ExeFen-PD | Guaifenesin; Phenylephrine Hydrochloride | Larken Laboratories |